- Home
- RNXT vs CALC Comparison
RNXT vs CALC Comparison
Compare RNXT & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- CALC
- Stock Information
- Founded
- RNXT 2012
- CALC 2011
- Country
- RNXT United States
- CALC United States
- Employees
- RNXT N/A
- CALC N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- RNXT Health Care
- CALC Health Care
- Exchange
- RNXT Nasdaq
- CALC Nasdaq
- Market Cap
- RNXT 33.8M
- CALC 40.3M
- IPO Year
- RNXT 2021
- CALC N/A
- Fundamental
- Price
- RNXT $1.50
- CALC $3.09
- Analyst Decision
- RNXT Strong Buy
- CALC Strong Buy
- Analyst Count
- RNXT 2
- CALC 5
- Target Price
- RNXT $6.50
- CALC $18.20
- AVG Volume (30 Days)
- RNXT 101.2K
- CALC 26.8K
- Earning Date
- RNXT 11-13-2024
- CALC 11-13-2024
- Dividend Yield
- RNXT N/A
- CALC N/A
- EPS Growth
- RNXT N/A
- CALC N/A
- EPS
- RNXT N/A
- CALC N/A
- Revenue
- RNXT N/A
- CALC N/A
- Revenue This Year
- RNXT N/A
- CALC N/A
- Revenue Next Year
- RNXT N/A
- CALC N/A
- P/E Ratio
- RNXT N/A
- CALC N/A
- Revenue Growth
- RNXT N/A
- CALC N/A
- 52 Week Low
- RNXT $0.77
- CALC $2.05
- 52 Week High
- RNXT $1.86
- CALC $8.38
- Technical
- Relative Strength Index (RSI)
- RNXT 64.78
- CALC 50.07
- Support Level
- RNXT $1.26
- CALC $2.73
- Resistance Level
- RNXT $1.60
- CALC $3.28
- Average True Range (ATR)
- RNXT 0.12
- CALC 0.29
- MACD
- RNXT 0.01
- CALC 0.02
- Stochastic Oscillator
- RNXT 72.22
- CALC 42.00
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.